SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shasun Pharmaceuticals clears US FDA and Brazilian ANVISA inspection

17 Jul 2013 Evaluate

Shasun Pharmaceuticals, a global pharmaceutical organization offering world class capabilities and facilities has successfully completed US FDA inspection during the first week of June 2013. The main focus of the inspection was for post approval of certain products which has been commercially launched recently by company’s customer in US. The company has informed that, on completion of the inspection, the US FDA authorities concluded that, the facility, systems and practices comply with US FDA requirements and there were no recommendations or observations.

The facility also underwent a Brazilian ANVISA (National Health Surveillance Agency) inspection in the first week of July 2013. This is a pre-approval inspection for an NDA product with a big pharmaceutical company associated with Shasun. The regulatory authorities concluded that the facility, systems and practices comply with ANVISA cGMP requirements.

Shasun Pharmaceuticals manufactures active pharmaceutical ingredients (APIs), their intermediates and enteric coating excipients with a significant presence in some key generics. Shasun has created a strong product portfolio, building on its R&D Expertise, regulatory capabilities and multi scale production capacities. It is one of the largest producers of Ibuprofen worldwide.

Peers
Company Name CMP
Sun Pharma Inds. 1677.90
Dr. Reddys Lab 1230.00
Cipla 1229.00
Zydus Lifesciences 932.15
Lupin 2333.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×